Pfizer Inc. Reports Positive Results in Studies of Toviaz, Pristiq, Chantix

Published: Jan 24, 2013

Pfizer Inc. (PFE) reported positive results in studies of an extended-release version of its Pristiq depression treatment, a higher dosage of its Toviaz urinary incontinence drug as well as the efficacy of smoking-cessation treatment Chantix among smokers whose previous attempts to quit have failed.

Back to news